Together, these data elucidate biological paradoxes of growth factor receptors and their isoforms in disease progression, validate the concept of selective targeting of conformational epitopes present in naturally occurring receptor isoforms of identical primary sequence, and validate selective activation of TrkC-FL as a therapeutic target in model of ALS. Here, NTRK3 is linked to amyotrophic lateral sclerosis.